• Je něco špatně v tomto záznamu ?

Regulation and role of endoglin in cholesterol-induced endothelial and vascular dysfunction in vivo and in vitro

M. Vicen, B. Vitverova, R. Havelek, K. Blazickova, M. Machacek, J. Rathouska, I. Najmanová, E. Dolezelova, A. Prasnicka, M. Sternak, C. Bernabeu, P. Nachtigal,

. 2019 ; 33 (5) : 6099-6114. [pub] 20190212

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20023962

Our objective was to investigate the effect of cholesterol [hypercholesterolemia and 7-ketocholesterol (7K)] on endoglin (Eng) expression and regulation with respect to endothelial or vascular dysfunction in vivo and in vitro. In vivo experiments were performed in 2-mo-old atherosclerosis-prone apolipoprotein E-deficient/LDL receptor-deficient (ApoE-/-/LDLR-/-) female mice and their wild-type C57BL/6J littermates. In in vitro experiments, human aortic endothelial cells (HAECs) were treated with 7K. ApoE-/-/LDLR-/- mice developed hypercholesterolemia accompanied by increased circulating levels of P-selectin and Eng and a disruption of NO metabolism. Functional analysis of the aorta demonstrated impaired vascular reactivity, and Western blot analysis revealed down-regulation of membrane Eng/Smad2/3/eNOS signaling in ApoE-/-/LDLR-/- mice. 7K increased Eng expression via Krüppel-like factor 6 (KLF6), liver X nuclear receptor, and NF-κB in HAECs. 7K-induced Eng expression was prevented by the treatment with 2-hydroxypropyl-β-cyclodextrin; 8-{[5-chloro-2-(4-methylpiperazin-1-yl) pyridine-4-carbonyl] amino}-1-(4-fluorophenyl)-4, 5-dihydrobenzo[g]indazole-3-carboxamide; or by KLF6 silencing. 7K induced increased adhesion and transmigration of monocytic human leukemia promonocytic cell line cells and was prevented by Eng silencing. We concluded that hypercholesterolemia altered Eng expression and signaling, followed by endothelial or vascular dysfunction before formation of atherosclerotic lesions in ApoE-/-/LDLR-/- mice. By contrast, 7K increased Eng expression and induced inflammation in HAECs, which was followed by an increased adhesion and transmigration of monocytes via endothelium, which was prevented by Eng inhibition. Thus, we propose a relevant role for Eng in endothelial or vascular dysfunction or inflammation when exposed to cholesterol.-Vicen, M., Vitverova, B., Havelek, R., Blazickova, K., Machacek, M., Rathouska, J., Najmanová, I., Dolezelova, E., Prasnicka, A., Sternak, M., Bernabeu, C., Nachtigal, P. Regulation and role of endoglin in cholesterol-induced endothelial and vascular dysfunction in vivo and in vitro.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20023962
003      
CZ-PrNML
005      
20201214131902.0
007      
ta
008      
201125s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1096/fj.201802245R $2 doi
035    __
$a (PubMed)30753095
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Vicen, Matej $u Department of Biological and Medical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.
245    10
$a Regulation and role of endoglin in cholesterol-induced endothelial and vascular dysfunction in vivo and in vitro / $c M. Vicen, B. Vitverova, R. Havelek, K. Blazickova, M. Machacek, J. Rathouska, I. Najmanová, E. Dolezelova, A. Prasnicka, M. Sternak, C. Bernabeu, P. Nachtigal,
520    9_
$a Our objective was to investigate the effect of cholesterol [hypercholesterolemia and 7-ketocholesterol (7K)] on endoglin (Eng) expression and regulation with respect to endothelial or vascular dysfunction in vivo and in vitro. In vivo experiments were performed in 2-mo-old atherosclerosis-prone apolipoprotein E-deficient/LDL receptor-deficient (ApoE-/-/LDLR-/-) female mice and their wild-type C57BL/6J littermates. In in vitro experiments, human aortic endothelial cells (HAECs) were treated with 7K. ApoE-/-/LDLR-/- mice developed hypercholesterolemia accompanied by increased circulating levels of P-selectin and Eng and a disruption of NO metabolism. Functional analysis of the aorta demonstrated impaired vascular reactivity, and Western blot analysis revealed down-regulation of membrane Eng/Smad2/3/eNOS signaling in ApoE-/-/LDLR-/- mice. 7K increased Eng expression via Krüppel-like factor 6 (KLF6), liver X nuclear receptor, and NF-κB in HAECs. 7K-induced Eng expression was prevented by the treatment with 2-hydroxypropyl-β-cyclodextrin; 8-{[5-chloro-2-(4-methylpiperazin-1-yl) pyridine-4-carbonyl] amino}-1-(4-fluorophenyl)-4, 5-dihydrobenzo[g]indazole-3-carboxamide; or by KLF6 silencing. 7K induced increased adhesion and transmigration of monocytic human leukemia promonocytic cell line cells and was prevented by Eng silencing. We concluded that hypercholesterolemia altered Eng expression and signaling, followed by endothelial or vascular dysfunction before formation of atherosclerotic lesions in ApoE-/-/LDLR-/- mice. By contrast, 7K increased Eng expression and induced inflammation in HAECs, which was followed by an increased adhesion and transmigration of monocytes via endothelium, which was prevented by Eng inhibition. Thus, we propose a relevant role for Eng in endothelial or vascular dysfunction or inflammation when exposed to cholesterol.-Vicen, M., Vitverova, B., Havelek, R., Blazickova, K., Machacek, M., Rathouska, J., Najmanová, I., Dolezelova, E., Prasnicka, A., Sternak, M., Bernabeu, C., Nachtigal, P. Regulation and role of endoglin in cholesterol-induced endothelial and vascular dysfunction in vivo and in vitro.
650    _2
$a zvířata $7 D000818
650    _2
$a aorta $x cytologie $x metabolismus $x patologie $7 D001011
650    _2
$a apolipoproteiny E $x genetika $7 D001057
650    _2
$a kultivované buňky $7 D002478
650    _2
$a cholesterol $x metabolismus $7 D002784
650    _2
$a endoglin $x genetika $x metabolismus $7 D000071063
650    _2
$a cévní endotel $x účinky léků $x metabolismus $x patologie $7 D004730
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a hypercholesterolemie $x komplikace $x genetika $x metabolismus $7 D006937
650    _2
$a indazoly $x farmakologie $7 D007191
650    _2
$a kyseliny isonikotinové $x farmakologie $7 D007539
650    _2
$a KLF6 $x metabolismus $7 D000075723
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a NF-kappa B $x metabolismus $7 D016328
650    _2
$a oxid dusnatý $x metabolismus $7 D009569
650    _2
$a synthasa oxidu dusnatého, typ III $x metabolismus $7 D052250
650    _2
$a P-selektin $x metabolismus $7 D019007
650    _2
$a aterosklerotický plát $x etiologie $x genetika $x metabolismus $7 D058226
650    _2
$a LDL-receptory $x genetika $7 D011973
650    _2
$a proteiny Smad $x metabolismus $7 D051785
650    _2
$a beta-cyklodextriny $x farmakologie $7 D047392
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vitverova, Barbora $u Department of Biological and Medical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.
700    1_
$a Havelek, Radim $u Department of Medical Biochemistry, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.
700    1_
$a Blazickova, Katerina $u Department of Biological and Medical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.
700    1_
$a Machacek, Miloslav $u Department of Biochemical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.
700    1_
$a Rathouska, Jana $u Department of Biological and Medical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.
700    1_
$a Najmanová, Iveta $u Department of Biological and Medical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.
700    1_
$a Dolezelova, Eva $u Department of Biological and Medical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.
700    1_
$a Prasnicka, Alena $u Department of Biological and Medical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.
700    1_
$a Sternak, Magdalena $u Jagiellonian Centre for Experimental Therapeutics (JCET), Bobrzynskiego, Krakow, Poland.
700    1_
$a Bernabeu, Carmelo $u Center for Biological Research, Spanish National Research Council (CSIC), Madrid, Spain. Biomedical Research Networking Center on Rare Diseases (CIBERER), Madrid, Spain.
700    1_
$a Nachtigal, Petr $u Department of Biological and Medical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.
773    0_
$w MED00001782 $t FASEB journal : official publication of the Federation of American Societies for Experimental Biology $x 1530-6860 $g Roč. 33, č. 5 (2019), s. 6099-6114
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30753095 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214131902 $b ABA008
999    __
$a ok $b bmc $g 1596281 $s 1114638
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 33 $c 5 $d 6099-6114 $e 20190212 $i 1530-6860 $m The FASEB journal $n FASEB J $x MED00001782
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Možnosti archivace